PRIMARY LYMPHOMA OF BONE - THE USE OF MRI IN PRETREATMENT EVALUATION

被引：37

作者：

SALTER, M

SOLLACCIO, RJ

BERNREUTER, WK

WEPPELMANN, B

机构：

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 02期

关键词：

D O I：

10.1097/00000421-198904000-00002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：101 / 105

页数：5

共 28 条

[1]

BACCI G, 1986, CANCER, V57, P1468, DOI 10.1002/1097-0142(19860415)57:8<1468::AID-CNCR2820570806>3.0.CO

[2]

2-0

[3]

BOSTON HC, 1974, CANCER-AM CANCER SOC, V34, P1131, DOI 10.1002/1097-0142(197410)34:4<1131::AID-CNCR2820340424>3.0.CO

[4]

2-X

[5]

CLAYTON F, 1987, CANCER, V60, P2494, DOI 10.1002/1097-0142(19871115)60:10<2494::AID-CNCR2820601025>3.0.CO

[6]

2-M

[7] MRI IN THE DETECTION OF MALIGNANT INFILTRATION OF BONE-MARROW [J].

DAFFNER, RH ;

LUPETIN, AR ;

DASH, N ;

DEEB, ZL ;

SEFCZEK, RJ ;

SCHAPIRO, RL .

[8]

DOSORETZ DE, 1982, CANCER-AM CANCER SOC, V50, P1009, DOI 10.1002/1097-0142(19820901)50:5<1009::AID-CNCR2820500532>3.0.CO

[9]

2-0

[10]

DOSORETZ DE, 1983, CANCER-AM CANCER SOC, V51, P44, DOI 10.1002/1097-0142(19830101)51:1<44::AID-CNCR2820510111>3.0.CO